Respiratory pharmacology. Antituberculosis drugs.
Tuberculosis remains a significant health problem. Its control and treatment depend on a thorough understanding of the basic principles and application of antituberculosis chemotherapy. The pharmacology of the major antituberculosis drugs is presented, including the management of adverse and allergic reactions.
D000636:Aminosalicylic Acids / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000378:metabolism / Q000627:therapeutic use*; D003524:Cyclosporins / Q000627:therapeutic use; D004977:Ethambutol / Q000627:therapeutic use; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D011718:Pyrazinamide / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use; D014376:Tuberculosis / Q000188:drug therapy
D000636:Aminosalicylic Acids; D000995:Antitubercular Agents; D003524:Cyclosporins; D011718:Pyrazinamide; D004977:Ethambutol; D007538:Isoniazid; D012293:Rifampin